Metoprolol Succinate
Product Images NDC 75834-291

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 75834-291). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5f23fe6d-figure-01 (5f23fe6d Figure 01)

Chemical structure of Metoprolol Succinate, showing the molecular components and arrangement for this extended-release active ingredient.*

FDA Label Image

1 (5f23fe6d Figure 02)

A forest plot graph titled 'Results for Subgroups in MERIT-HE' showing relative risk and 95% confidence intervals for various subgroups comparing metoprolol succinate extended release tablets to placebo. The graph is divided into three sections covering total mortality, total mortality or all-cause hospitalization (time to first event), and total mortality or hospitalization for heart failure (time to first event). Each section includes subgroup categories such as geographic location, NYHA class, ejection fraction, ischemic etiology, sex, race, previous MI, diabetes mellitus, hypertension status, and heart rate.*

FDA Label Image

3 (Mts25 1000ct)

Label for Metoprolol Succinate Extended-Release Tablets USP, 25 mg strength. The label indicates a package of 1000 tablets manufactured for Nivagen Pharmaceuticals, Inc. The label includes storage instructions, a barcode, and the NDC number 75834-290-00.*

FDA Label Image

1 (Mts25 100ct)

Metoprolol Succinate Extended-Release Tablets USP 25 mg, 100 count, from Nivagen Pharmaceuticals, Inc. The label includes NDC 75834-290-01, storage instructions, warnings, and contact information. The product is prescription only.*

FDA Label Image

2 (Mts25 500ct)

Label for Metoprolol Succinate Extended-Release Tablets USP, 25 mg strength. The label indicates 500 tablets in the package for Rx-only use. Manufactured for Nivagen Pharmaceuticals, Inc., with storage instructions and warnings included. The label displays NDC 75834-290-05 and includes a barcode.*

FDA Label Image

6 (Mts50 1000ct)

Label for Metoprolol Succinate Extended-Release Tablets USP, 50 mg strength, manufactured for Nivagen Pharmaceuticals, Inc. The label indicates a package size of 1000 tablets, includes storage instructions, a barcode, and a toll-free number. The label is primarily white with red and blue accents.*

FDA Label Image

4 (Mts50 100ct)

Metoprolol Succinate Extended-Release Tablets USP 50 mg, label for 100 tablets by Nivagen Pharmaceuticals, Inc. The label includes dosage strength, package quantity, NDC number 75834-291-01, barcode, and storage instructions, with manufacturer contact details and a warning to keep out of reach of children.*

FDA Label Image

5 (Mts50 500ct)

Metoprolol Succinate 50 mg extended-release tablets label from Nivagen Pharmaceuticals, Inc. The label indicates the product is an Rx only with 500 tablets in the package. It includes storage instructions, a warning to keep out of reach of children, and references to the USP for dosage and container information. The label shows the NDC number 75834-291-05 and includes a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.